Jasper Therapeutics Correlations
| JSPR Stock | USD 1.78 0.05 2.73% |
The current 90-days correlation between Jasper Therapeutics and IO Biotech is 0.17 (i.e., Average diversification). The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Jasper Therapeutics Correlation With Market
Modest diversification
The correlation between Jasper Therapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Jasper Stock
Moving against Jasper Stock
| 0.74 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.7 | CMB | Cambium Bio | PairCorr |
| 0.68 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.64 | RAC | Race Oncology | PairCorr |
| 0.61 | VANI | Vivani Medical | PairCorr |
| 0.6 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.53 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.49 | VERA | Vera Therapeutics | PairCorr |
| 0.45 | 688578 | Shanghai Allist Phar | PairCorr |
| 0.35 | PANACEABIO | Panacea Biotec Earnings Call This Week | PairCorr |
| 0.69 | DRTS | Alpha Tau Medical | PairCorr |
| 0.68 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
| 0.63 | DSGN | Design Therapeutics Buyout Trend | PairCorr |
| 0.61 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.55 | DTIL | Precision BioSciences | PairCorr |
| 0.46 | DXB | Dimerix | PairCorr |
| 0.46 | DWTX | Dogwood Therapeutics, | PairCorr |
| 0.34 | VIVS | VivoSim Labs, Symbol Change | PairCorr |
| 0.82 | VTVT | vTv Therapeutics | PairCorr |
| 0.73 | VRDN | Viridian Therapeutics | PairCorr |
| 0.66 | BSFA | BSF Enterprise Plc | PairCorr |
| 0.6 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.49 | VRTX | Vertex Pharmaceuticals Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jasper Stock performing well and Jasper Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jasper Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IOBT | 8.89 | 1.32 | 0.09 | 1.01 | 13.44 | 24.24 | 145.33 | |||
| ADAP | 12.71 | 0.86 | 0.04 | (0.58) | 14.98 | 22.82 | 168.52 | |||
| PSTV | 6.31 | (0.17) | 0.00 | (0.12) | 0.00 | 16.67 | 58.07 | |||
| EYEN | 15.39 | 6.23 | 0.54 | (5.94) | 8.34 | 50.96 | 165.38 | |||
| VRCA | 3.13 | (0.80) | 0.00 | (4.20) | 0.00 | 5.51 | 20.24 | |||
| OKUR | 3.65 | 0.83 | 0.21 | (2.44) | 2.99 | 10.67 | 26.72 | |||
| RVPH | 7.30 | 0.55 | 0.06 | 0.32 | 8.62 | 21.82 | 55.16 | |||
| GBIO | 3.41 | 0.22 | 0.16 | 0.15 | 2.58 | 5.41 | 70.14 | |||
| FGEN | 3.23 | 0.40 | 0.15 | 0.29 | 2.79 | 8.13 | 26.84 | |||
| LVTX | 1.12 | 0.15 | 0.00 | (0.17) | 1.10 | 1.97 | 12.11 |
Jasper Therapeutics Corporate Management
| Kimberly Baxter | VP Quality | Profile | |
| Daniel MD | Member Officer | Profile | |
| Luca Noto | Senior Operations | Profile | |
| Carol Zoltowski | VP Quality | Profile |